Information relating to COVID-19 pandemic from COST can be found here
Leading Interational Vaccinology Education
A Programme of Excellence in Learning and Research, Looking for Biochemists, Bioengineers, Biologists, Clinicians, Pharmacists and Veterinarians
ENOVA partners publish review article on the use of adjuvants to boost therapeutic vaccines
Reports of ENOVA short term missions are now available on our website
Open Call: Apply for TRANSVAC2 Vaccine Development Services
WHO today published a "draft landscape of COVID-19 candidate vaccines". A total of 133 vaccines (10 are in clinical trials) covering various platforms (inactivated virus, recombinant virus and proteins, VLPs, DNA/RNA vaccines) are listed. Adjuvants like Alum, Matrix M, AdvaxTM , CPG1018 and others are included as immune stimulants in the race for this vaccine.